1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. Recordati
  6. News
  7. Sector news
    REC   IT0003828271

RECORDATI

(REC)
  Report
Delayed Borsa Italiana  -  05/17 11:38:14 am EDT
41.87 EUR   +0.10%
05/10Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10Recordati Industria Chimica Seeks M&A
CI
05/10TRANSCRIPT : Recordati Industria Chimica e Farmaceutica S.p.A., Q1 2022 Earnings Call, May 10, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
01:28pPfizer-BioNTech COVID-19 Vaccine Booster Approved for Children 5 to 11 Years Old in US
MT
12:18pINSIDER SELL : Pfizer
MT
11:50aPfizer, BioNTech Receive US Approval for COVID-19 Jab Booster Dose for Children
MT
11:12aPfizer Gets FDA Emergency Use Authorization for COVID-19 Vaccine as Booster Dose in Chi..
MT
09:29aAlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation
MT
08:55aFDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
DJ
08:54aCitigroup Adjusts Price Target on Johnson & Johnson to $205 From $210, Reiterates Buy R..
MT
08:49aPRESS RELEASE : Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech..
DJ
08:41aPFIZER INC : Barclays remains Neutral
MD
05/16Mirati Therapeutics Appoints Laurie Stelzer CFO
MT
05/16Berkshire Hathaway Exited Bristol Myers and AbbVie Stakes in 1Q
DJ
05/16Eli Lilly Says FDA Approves Mounjaro Injection to Control Diabetes; Shares Rise
MT
05/16GLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
05/16AbbVie Receives Option to License Worldwide Rights to Cugene's CUG252 for Autoimmune, I..
MT
05/16TRANSCRIPT : Roche Holding AG - Special Call
CI
05/16INSIDER SELL : Pfizer
MT
05/15Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU
MT
05/13FDA Approves Lilly's Mounjaro (Tirzepatide) Injection, the First and Only GIP and GLP-1..
CI
05/13FDA Approves Eli Lilly's Novel, Dual-Targeted Treatment for Type 2 Diabetes
MT
05/13Berenberg Bank Adjusts Eli Lilly's Price Target to $345 From $305, Maintains Buy Rating
MT
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13ROCHE HOLDINGS AG : Reduced to Neutral by Jefferies
MD
05/12Roche believes cancer drug setback not a fatal blow to growth prospects
RE
05/12ROCHE HOLDINGS AG : Gets a Neutral rating from Morgan Stanley
MD
05/12ROCHE HOLDINGS AG : Deutsche Bank lowers his opinion and switches to Neutral
MD
05/12Roche Teams Up With Global Fund To Boost Diagnostic Systems In Low, Middle-income Natio..
MT
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11Declaration of Voting Results by AbbVie Inc
CI
05/11TRANSCRIPT : Johnson & Johnson Presents at Bank of America 2022 Healthcare Conference, May..
CI
05/11New class of cancer drugs down, not out, after Roche trial setback - analysts
RE
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11Pfizer's South Africa COVID-19 Jab Production Plans Faces Scaleback As Demand Thins Out
MT
05/11AbbVie Says Its Crohn's Disease Therapy Performed 'Significantly' Better Than Placebo i..
MT
05/11Roche, Electronic Health Solutions Team-Up on Healthcare Tech in Jordan
MT
05/11Deutsche Bank Lowers Price Target on Roche, Downgrades Recommendation to Hold From Buy
MT
05/11ROCHE HOLDINGS AG : Receives a Buy rating from Bernstein
MD
05/11ROCHE HOLDINGS AG : Goldman Sachs gives a Buy rating
MD
05/11Correction to AbbVie Upadacitinib Story
DJ
05/11AbbVie Inc. Achieved Clinical Remission and Endoscopic Response At One Year in Phase 3 ..
CI
05/11ROCHE HOLDINGS AG : Barclays reiterates its Buy rating
MD
05/11ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating
MD
05/11Johnson & Johnson Names Thibaut Mongon CEO Designate of Planned New Consumer Health Com..
MT
05/11Eli Lilly and Incyte Say Olumiant, Their COVID-19 Treatment for Hospitalized Adults, Ap..
MT
05/11Johnson & Johnson Appoints CEO For Future Spin-off Unit
MT
05/11ROCHE HOLDINGS AG : UBS reaffirms its Sell rating
MD
05/11ABBVIE : Upadacitinib Achieved Clinical Remission at One Year in Crohn's Disease
DJ
05/11Johnson & Johnson Announces Management Appointments for Planned New Consumer Health Com..
CI
05/11FDA Approves Lilly, Incyte Drug Olumiant for Certain Hospitalized Covid Patients
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on RECORDATI